Your browser doesn't support javascript.
loading
Adherence to pretreatment and intratreatment imaging of head and neck squamous cell carcinoma patients undergoing (chemo) radiotherapy in a research setting.
Martens, Roland M; Koopman, Thomas; Noij, Daniel P; de Bree, Remco; Vergeer, Marije R; Zwezerijnen, Gerben; Leemans, C René; de Graaf, Pim; Boellaard, Ronald; Castelijns, Jonas A.
Afiliação
  • Martens RM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands. Electronic address: ro.martens@amsterdamumc.nl.
  • Koopman T; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • Noij DP; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Vergeer MR; Department of Radiation Oncology, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • Zwezerijnen G; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • Leemans CR; Department of Otolaryngology - Head and Neck Surgery, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • de Graaf P; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • Boellaard R; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
  • Castelijns JA; Department of Radiology and Nuclear Medicine, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands.
Clin Imaging ; 69: 82-90, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32693228
ABSTRACT

PURPOSE:

The emerge of improved personalized treatment adaptations and outcome prediction is accompanied with increasing non-invasive assessments in early treatment phase, leading to increased patient burden. This study assessed the adherence of patients with head and neck squamous cell carcinoma (HNSCC) to undergo pretreatment and research-related intratreatment imaging, and assessed which factors caused drop-out.

METHOD:

Between 2013 and 2019, advanced-staged HNSCC patients were prospectively included, underwent (chemo) radiotherapy with curative intent and planned for both pre-treatment and intratreatment sequential 18F-FDG-PET/CT, 18F-FDG-PET/MRI and thereafter MRI (including DWI/DCE). Drop-out-factors were described as healthcare-related (logistics and imaging-system defects) and patient-related (psychological, physical, not-specified). Common Toxicity Criteria (CTC) were routinely scored by radiation/medical oncologists throughout the first 3 weeks, and compared between patient drop-outs and who complete imaging.

RESULTS:

Ninety-seven patients (mean age 61 ± 6.8 years) were included; 95 patients (97.9%) underwent pretreatment imaging and 63 (64.9%) intratreatment imaging. For 18F-FDG-PET/CT, 18F-FDG-PET/MRI and MRI pretreatment drop-outs were 2, 10 and 3 patients and for intratreatment drop-outs were 34, 39 and 35 patients, respectively. Patient-related drop-out-factors were physical (n = 16, e.g. dysphagia), psychological (n = 6, e.g. claustrophobia) and non-specified (n = 12). Healthcare-related drop-out-factors were logistics (n = 6) and 18F-FDG-PET/CT-/MRI-system defects (n = 2). The CTC mucosal toxicity was significantly higher (p = 0.023) at week 2 of (chemo)radiotherapy in patient drop-outs than with complete imaging.

CONCLUSIONS:

The drop-out frequency of advanced-staged HNSCC patients for imaging during (chemo)radiotherapy in a research-setting was high and mainly patient-related. Treatment of patient-related inconveniences, communication of rationale and healthcare-related imaging protocol efficiency improvements may contribute to improved adherence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article